RU93044224A - PHARMACEUTICAL COMPOSITION POSSESSING AGONISTIC ACTIVITY FOR 5 NT1 - SIMILAR RECEPTORS - Google Patents

PHARMACEUTICAL COMPOSITION POSSESSING AGONISTIC ACTIVITY FOR 5 NT1 - SIMILAR RECEPTORS

Info

Publication number
RU93044224A
RU93044224A RU93044224/14A RU93044224A RU93044224A RU 93044224 A RU93044224 A RU 93044224A RU 93044224/14 A RU93044224/14 A RU 93044224/14A RU 93044224 A RU93044224 A RU 93044224A RU 93044224 A RU93044224 A RU 93044224A
Authority
RU
Russia
Prior art keywords
agonistic activity
pharmaceutical composition
composition possessing
similar receptors
receptors
Prior art date
Application number
RU93044224/14A
Other languages
Russian (ru)
Other versions
RU2110992C1 (en
Inventor
Эмиль Эдуард Шаффер Ален
Original Assignee
Лаборатуар Глаксо С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909027827A external-priority patent/GB9027827D0/en
Application filed by Лаборатуар Глаксо С.А. filed Critical Лаборатуар Глаксо С.А.
Publication of RU93044224A publication Critical patent/RU93044224A/en
Application granted granted Critical
Publication of RU2110992C1 publication Critical patent/RU2110992C1/en

Links

Claims (1)

Изобретение касается шипучих фармацевтических композиций для орального применения, содержащих шипучий комплекс, состоящий из основного и кислотного компонентов, реагирующих в присутствии воды с выделением газа, и соединение, обладающее агонистической активностью для 5НТ1-подобных рецепторов, или его фармацевтически приемлемую соль или сольват. Описаны способы получения таких композиций и их применение для лечения головных болей.The invention relates to effervescent pharmaceutical compositions for oral administration containing an effervescent complex consisting of a basic and acidic components, reacting in the presence of water to produce gas, and a compound having agonistic activity for 5HT 1 -like receptors, or a pharmaceutically acceptable salt or solvate thereof. Describes how to obtain such compositions and their use for the treatment of headaches.
RU93044224A 1990-12-21 1991-12-17 Carbonated pharmaceutical composition for oral administration RU2110992C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9027827.6 1990-12-21
GB909027827A GB9027827D0 (en) 1990-12-21 1990-12-21 Pharmaceutical compositions
PCT/EP1991/002425 WO1992011003A1 (en) 1990-12-21 1991-12-17 Pharmaceutical compositions
SG169594A SG169594G (en) 1990-12-21 1994-12-01 Effervescent pharmaceutical compositions containing a 5HT-receptor agonist

Publications (2)

Publication Number Publication Date
RU93044224A true RU93044224A (en) 1997-01-27
RU2110992C1 RU2110992C1 (en) 1998-05-20

Family

ID=26298162

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93044224A RU2110992C1 (en) 1990-12-21 1991-12-17 Carbonated pharmaceutical composition for oral administration

Country Status (25)

Country Link
EP (1) EP0563094B1 (en)
JP (1) JP3425949B2 (en)
KR (1) KR100188172B1 (en)
AT (1) ATE127688T1 (en)
AU (1) AU654313B2 (en)
BE (1) BE1004182A3 (en)
CA (1) CA2099585C (en)
CH (1) CH684161A5 (en)
CZ (1) CZ281042B6 (en)
DE (1) DE69113062T2 (en)
DK (1) DK0563094T3 (en)
ES (1) ES2078727T3 (en)
FR (1) FR2670674B1 (en)
GB (2) GB9027827D0 (en)
GR (1) GR3017701T3 (en)
HK (1) HK18795A (en)
IE (1) IE914482A1 (en)
IL (1) IL100452A (en)
IT (1) IT1252599B (en)
MX (1) MX9102733A (en)
NZ (1) NZ241098A (en)
RU (1) RU2110992C1 (en)
SG (1) SG169594G (en)
WO (1) WO1992011003A1 (en)
ZA (1) ZA9110052B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714064B1 (en) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame for its application as a therapeutically active substance.
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
FR2593065B1 (en) * 1986-01-22 1988-09-09 Smith Kline French Lab EFFERVESCENT COUPLES, EFFERVESCENT COMPOSITIONS OF HISTAMINE H2 ANTAGONISTS CONTAINING THEM AND THEIR PREPARATION.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Similar Documents

Publication Publication Date Title
CA2293823A1 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
DE122010000050I1 (en) SUBLINGUAL OR BUKKALES MEDICINES
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
CA2124677A1 (en) Immunopotentiatory agents and physiologically acceptable salts thereof
IL149496A (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
RU93004793A (en) HINAZOLIN DERIVATIVES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS
IL97892A0 (en) 2,9-disubstituted-4h-pyrido(1,2-a)pyrimidin-4-ones,their preparation and pharmaceutical compositions containing them
CA2202397A1 (en) Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
CA2127472A1 (en) New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
RU93004535A (en) COMPOUNDS, METHOD OF OBTAINING AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
IT9019112A1 (en) PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR THE ORAL ADMINISTRATION OF CALCITONIN
YU242789A (en) New compound, 4-fluoro-2-//(4-metoxy-2-pyridin-yl)methylsulphinyl/-1h-benzimidazole and process for obtaining
RU93044224A (en) PHARMACEUTICAL COMPOSITION POSSESSING AGONISTIC ACTIVITY FOR 5 NT1 - SIMILAR RECEPTORS
IT9019793A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
SE8402199L (en) PHARMACEUTICAL PREPARATION CONTAINING CO-DERGOCRIN AND A CALCIUM ANTAGONIST
SE9202218D0 (en) PHARMACOLOGICALLY ACTIVE ALFA (TERTIARY AMINOMETHYL) -BENZENEMETHANOL DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEM, THERAPEUTICAL USE THEREOF AND PROCESSES FOR THEIR PREPARATION
CA2423288A1 (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
ITRM950589A0 (en) USE OF NATURAL CYTOKINE MUTEINS AS IMMUNOGENS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS TO TREAT OR PREVENT DISEASES CAUSED BY THE OVERPRODUCTION OF THESE NATURAL CYTOKINES, AND PHARMACEUTICAL COMPOSITIONS SO OBTAINABLE
IT9021021A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF HIRUDIN
CA2099585A1 (en) Pharmaceutical compositions
ITMI911445A0 (en) USE OF PHOSPHOLIPIDE DERIVATIVES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING IMMUNOSUPPRESSIVE ACTIVITY
HU9503351D0 (en) Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
GB9211277D0 (en) Pharmaceutical compositions